Clinical Trials Logo

Long QT Syndrome Type 3 clinical trials

View clinical trials related to Long QT Syndrome Type 3.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT01728025 Recruiting - Clinical trials for Long QT Syndrome Type 3

Long Term Prophylactic Therapy of Congenital Long QT Syndrome Type III (LQT3) With Ranolazine

Start date: October 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether ranolazine will reduce the risk of arrhythmic events in patients with long QT syndrome type 3.